Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Julie Denny
  • June 28, 2016
  • Webinars

What next for biosimilars?

What next for biosimilars?

Biosimilar medicines appear to present a significant opportunity to introduce cutting-edge therapies to the treatment landscape for many diseases, while also addressing the cost-effectiveness demands now being made on global healthcare systems. However, these drugs aren’t cheap or easy to manufacture and come with considerable marketing challenges.
Join market research consultants Laurent Chanroux and Richard Head for this complimentary webinar in which they will explore and compare biosimilars in RA and diabetes.

read more »

  • Posted by Julie Denny
  • June 21, 2016
  • Webinars

Understanding the Chronic Disease Patient Journey in Emerging Markets

Understanding the Chronic Disease Patient Journey in Emerging Markets

With growing urban populations and increasing purchasing power, emerging markets remain an attractive prospect for growth. A high proportion of the urban emerging market population already suffer from  chronic diseases and prevalence is set to further increase as lifestyles become closer to those in the West.
The chronic disease patient is a critical stakeholder in emerging markets because they often have to pay for their healthcare out of pocket. Moreover these markets often don’t have formal primary care systems, so the patient is the only constant in the journey. Understanding their journey is critical in order to fully exploit these potential new markets.

read more »

  • Posted by Julie Denny
  • April 5, 2016
  • Webinars

Understanding the Chronic Disease Patient Journey in Emerging Markets

Understanding the Chronic Disease Patient Journey in Emerging Markets

With growing urban populations and increasing purchasing power, emerging markets remain an attractive prospect for growth. A high proportion of the urban emerging market population already suffer from  chronic diseases and prevalence is set to further increase as lifestyles become closer to those in the West.
The chronic disease patient is a critical stakeholder in emerging markets because they often have to pay for their healthcare out of pocket. Moreover these markets often don’t have formal primary care systems, so the patient is the only constant in the journey. Understanding their journey is critical in order to fully exploit these potential new markets.

read more »

  • Posted by Julie Denny
  • February 24, 2016
  • Webinars

The Art of Storytelling in Pharma Market Research

The Art of Storytelling in Pharma Market Research

Effectively communicating research insights is a major focus for today’s market researcher, particularly in global healthcare. It’s not enough now just to present the research evidence. We must tell the story, using a clear narrative to engage a broad and often disparate group of stakeholders. In this short webinar we will explore the principles of storytelling in pharma market research and show you how you to find and share your story.   

read more »

Understanding the Patient Journey in China 2015

Understanding the Patient Journey in China 2015

The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar (the latest in our  series on China and emerging markets) will examine the likely impact on the patient journey and consider the possible implications for market researchers.

read more »